Home  /  Resource Library  /  Brentuximab Vedotin Combined With Chemotherapy in Patients With Newly Diagnosed Early-Stage, Unfavorable-Risk Hodgkin Lymphoma

Brentuximab Vedotin Combined With Chemotherapy in Patients With Newly Diagnosed Early-Stage, Unfavorable-Risk Hodgkin Lymphoma

Results of a study examining brentuximab vedotin combined with chemotherapy for first line treatment of Hodgkin lymphoma.